Plus Therapeutics, Inc
Price
FilingsNewest: 8-K, Other eventsOct 2 →Insiders1 insider bought $10,200 in 1 open-market buy. No sales.→Financing →PeersClosest companies: CLRB, NGNE, SLDB→
From the filings
Figures
- Revenue
- $4.2Mlast 12 months
- Net income
- −$26.1Mlast 12 months
- Operating cash flow
- −$20.8Mlast 12 months
- Cash and equivalents
- $2.4Mat the last balance sheet
- Shares outstanding
- 7.3M shareson issue